<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/530703</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T11:21:45.000Z</news:publication_date>
      <news:title>GSK pledges $800M to add biologics production capabilities in Pennsylvania</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/530679</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T11:00:35.000Z</news:publication_date>
      <news:title>Undecimal Bio launches with $18M to take siRNA beyond liver disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/530031</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T07:00:00.000Z</news:publication_date>
      <news:title>Strategic CDMO partnerships shift from transactional to collaborative, emphasizing risk sharing and regulatory expertise</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/529587</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T05:01:00.000Z</news:publication_date>
      <news:title>Integrating Multiple Stability Measurements Improves Early Biologics Testing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/529982</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-12T02:55:00.000Z</news:publication_date>
      <news:title>Merck’s deeper dive into efficacy, safety of $1.3B eye disease drug raises fears of ‘limited’ potential</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/528111</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-11T21:00:05.000Z</news:publication_date>
      <news:title>AstraZeneca attributes Phase 3 failure of bone disease enzyme therapy to trial design flaws</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/523919</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-10T23:01:00.000Z</news:publication_date>
      <news:title>Americans show higher trust in science than most countries, survey finds</news:title>
    </news:news>
  </url>
</urlset>
